James H. Sabry, Executive Chairman at CYTOKINETICS INC (CYTK), sold 7,000 shares at $5.00 ($35K) on 2007-12-03, disclosed to the SEC on 2007-12-03.
Scheduled sale ($35k) by Executive Chairman under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| CYTK | SELL | 2010-05-14 | $30K | — | Filing → |
| CYTK | SELL | 2010-04-28 | $32K | — | Filing → |
| CYTK | SELL | 2010-04-01 | $32K | — | Filing → |